He discusses his research on the overall risk and temporal trends of venous thromboembolism, deep vein thrombosis, and pulmonary embolism in patients with gout.
Dr Solomon discusses what rheumatologists should know about interleukin-1β inhibitors, his research on the relationship between the inhibitors and gout, and more.
